
Harmonic's sales surge reaches beyond its two key customers
Harmonic beat its Q3 sales forecast as customers beyond two key accounts supplied all net sequential growth. We compare the customer shift, new orders and higher outlook.
Beyond the headline.
Inside the numbers.
Ticker Byline
Page 4. Quarterly results, changing forecasts and the operating trends behind company performance.

Harmonic beat its Q3 sales forecast as customers beyond two key accounts supplied all net sequential growth. We compare the customer shift, new orders and higher outlook.

Tennant's robotics revenue jumped 71% in Q3. We separate the tariff-refund benefit from the margin recovery and compare the unchanged annual profit target.

Ichor's Q3 earnings exceeded its own forecast while cash fell $43 million. We compare the profit improvement, inventory build and earlier share sale.

Roku's advertising and subscriptions grew at similar rates in Q3. A segment comparison shows why ads supplied almost all the increase in total gross profit.

Cabot's Reinforcement Materials volumes rose 5% in fiscal Q4 while segment profit fell. We compare the specialty recovery, earlier targets and 2027 outlook.

A deferred rent receipt supplied about 57% of Sabra's Q3 rental revenue increase. We compare AFFO, normalized earnings and the changed annual outlook.

Spire Missouri seeks about $171 million of net new annual revenue after nearly $808 million of investment since its last rate case. We examine the proposal.

Valaris delivered promised drillship starts and improved sequential results. Our calculation shows cash from operations still trailing capital spending by $54 million.

BWXT raised its preliminary 2027 earnings outlook, while cash growth is expected to remain modest. We trace working capital, spending and the medical sale.

Neurocrine raised its Ingrezza sales target and lowered its selling expense forecast. We calculate the Q4 requirement and compare two full quarters of Vykat sales.

Jazz raised its sales outlook, but Actio’s $754 million research expense remains in adjusted earnings. Our comparison traces the cash cost and implied fourth-quarter sales.

Advanced Energy beat its sales and earnings forecasts, while inventory and investment absorbed cash. Our comparison traces the nine-month cash flow and debt refinancing.

Earnings & Outlook · CRBG · EQH
Corebridge’s operating earnings per share rose 27%, while adjusted profit grew 5%. Our comparison traces share counts and special items ahead of the Equitable merger.

Allison’s truck rebound is lifting cash flow after a $2.6 billion acquisition. Our comparison tests the recovery and traces the higher annual cash forecast.

BioMarin reached its first billion-dollar sales quarter, then cut its annual earnings forecast. Our comparison traces research costs, acquired revenue and order timing.

Fabrinet's sales rose 51%, while operating cash flow fell 79%. Our analysis traces inventory, investment funding and the gap between reported and adjusted earnings.

Entergy raised its annual earnings floor after a strong quarter. Our comparison measures weather’s contribution and examines demand and financing costs.

PSEG kept its annual adjusted earnings target despite a sharp decline in reported profit. Our comparison explains the accounting swing and utility funding pressure.